Despite being treatable and preventable, malaria kills about half a million people each year,
mostly in Africa. Notwithstanding many attempts to develop a malaria vaccine, only the …

Vaccination of malaria-naive volunteers with a high dose of Plasmodium falciparum
sporozoites chemoattenuated by chloroquine (CQ)(PfSPZ-CVac [CQ]) has previously …

Despite considerable efforts and achievements, malaria continues to be one of the most
devastating infectious diseases in the world. Clearly, an effective vaccine against malaria …

Malaria vaccine development entered a new era in 2015 when the pre-erythrocytic
Plasmodium falciparum candidate RTS, S was favorably reviewed by the European …

The currently available malaria control tools have allowed malaria elimination in many
regions but there remain many regions where malaria control has made little progress. A …

On Oct 6, WHO announced that it will be recommending widespread use of the RTS, S/AS01
(RTS, S) malaria vaccine for children in sub-Saharan Africa and in other regions with …

Extensive control efforts have significantly reduced malaria cases and deaths over the past
two decades, but in recent years, coupled with the COVID-19 pandemic, success has …

Despite novel global measures to combat malaria, the disease remains a considerable
healthcare burden especially in resource limited settings. It accounts for over 2 million …

Malaria is estimated by the World Health Organization (WHO) to have killed 627,000
individuals worldwide in 2020, with nearly 80% of deaths in African children younger than …

Abstract The Malaria Vaccine Symposium occurred at Johns Hopkins University in
Baltimore, MD, USA on April 25th, 2017, coinciding with World Malaria Day and the WHO …